Molecular Partners AG
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
MOLN | SW
Overview
Corporate Details
- ISIN(s):
- CH0256379097 (+1 more)
- LEI:
- 875500AXMLDAZ4D21744
- Country:
- Switzerland
- Address:
- Wagistrasse 14, 8952 Schlieren
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Molecular Partners AG is a clinical-stage biopharmaceutical company that pioneers the design and development of DARPin therapeutics, a novel class of custom-built protein drugs. The company leverages its proprietary platform to create potent and specific therapies engineered to address complex medical challenges, particularly in oncology and virology, that other drug modalities cannot readily treat. Molecular Partners develops its pipeline of innovative therapeutic candidates independently and in collaboration with global partners to deliver new treatments for patients with serious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-07-07 07:25 |
Share Issue/Capital Change
Molecular Partners AG: Molecular Partners Successfully Completes the Launch of …
|
English | 17.3 KB | ||
| 2020-04-19 23:15 |
Regulatory Filings
Molecular Partners Initiates Anti-COVID-19 Therapeutic Program Leveraging Multi…
|
English | 12.0 KB |
Automate Your Workflow. Get a real-time feed of all Molecular Partners AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Molecular Partners AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Molecular Partners AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-09 | N/A | Executive member | Sell | None | 47,784.80 CHF |
| 2024-09-09 | N/A | Executive member | Sell | None | 13,822.40 CHF |
| 2024-04-02 | N/A | Executive member | Sell | None | 243,000.00 CHF |
| 2023-11-01 | N/A | Executive member | Buy | None | 31,760.55 CHF |
| 2022-02-15 | N/A | Executive member | Sell | None | 2,410,500.00 CHF |
| 2022-02-15 | N/A | Executive member | Sell | None | 1,607,000.00 CHF |
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}